Pharma Capital
CompanyCurrent (p)Volume
Sarossa (SARS) 1.52 14,021,775
GlaxoSmithKline (GSK) 1518.50 9,936,536
AstraZeneca (AZN) 4481.50 4,372,237
Indivior (INDV) 368.20 3,264,679
GW Pharmaceuticals (GWP) 735.00 2,319,262
Oxford Biomedica (OXB) 8.58 2,313,206
Shire (SHP) 4262.50 1,976,387
Vectura (VEC) 114.50 1,110,163
Alliance Pharma (APH) 51.25 724,751
Hikma Pharmaceuticals (HIK) 1399.00 619,068
SkyePharma (SKP) 443.00 524,876
BTG (BTG) 652.50 366,122
Abcam (ABC) 1023.00 195,697
Sinclair IS Pharma (SPH) 29.75 182,829
Proteome Sciences (PRM) 3.68 170,000
Dechra Pharmaceuticals (DPH) 1728.00 153,481
Clinigen Group (CLIN) 991.50 87,764
Source BioScience (SBS) 17.50 53,000
Silence Therapeutics (SLN) 135.00 41,111
Immupharma (IMM) 57.88 39,156
Genus (GNS) 1734.00 30,651
Tiziana Life Sciences (TILS) 171.38 25,000
Taihua (TAIH) 0.88 15,470
Circassia Pharmaceuticals (CIR) 89.13 9,462
Quantum Pharma (QP.) 55.38 6,721
4d pharma (DDDD) 246.00 6,252
Diurnal Group (DNL) 131.00 0
Evgen Pharma (EVG) 21.50 0
e-Therapeutics (ETX) 12.25 0
Ergomed (ERGO) 192.50 0

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.